Get the Stockscreener App
0.67
2.32%
-0.0159
Pre-market:
.67
cbdMD Inc stock is traded at $0.67, with a volume of 85,448.
It is down -2.32% in the last 24 hours and down -12.67% over the past month.
See More
Previous Close:
$0.6859
Open:
$0.693
24h Volume:
85,448
Relative Volume:
0.07
Market Cap:
$7.03M
Revenue:
$19.98M
Net Income/Loss:
$-2.66M
P/E Ratio:
-1.6393
EPS:
-0.4087
Net Cash Flow:
$-2.65M
1W Performance:
-6.94%
1M Performance:
-12.67%
6M Performance:
-44.17%
1Y Performance:
-22.00%
1-Day Range:
$0.67
$0.7199
1-Week Range:
$0.67
$0.74
52-Week Range:
$0.4701
$2.56
cbdMD Inc Stock (YCBD) Company Profile
Compare YCBD vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.67 | 7.03M | 19.98M | -2.66M | -2.65M | -0.4087 |
TAK
Takeda Pharmaceutical Co Adr
|
15.77 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.07 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.69 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.95 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.57 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
cbdMD Inc Stock (YCBD) Latest News
cbdMD Inc. (YCBD) Slides Further as It Tests Key Support LevelWatchlist Stock Ideas - newsline.com
cbdMD Inc. (YCBD) Edges Higher Amid Tight Trading Range – Key Levels in FocusAdaptive Moving Average - newsline.com
cbdMD Inc. (YCBD) Slips 1.4% as Price Hovers Near Key SupportPut Wall - newsline.com
cbdMD Inc. (YCBD) Continues Slide, Testing Key Support at $0.68AAII Bullish - newsline.com
YCBD Q1 2026 Earnings: EPS Miss Highlights Continuing Operational ChallengesRevenue Estimate Trend - newsline.com
YCBD Q1 2026 Earnings: EPS Falls Short of Estimates Amid Continued Operational ChallengesCapex Guidance - newsline.com
Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results - Insider Monkey
YCBD Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesEarnings Call Highlights - newsline.com
cbdMD Inc. (YCBD) Surges 7.97% as Price Approaches Key ResistanceBPI Bear Correction - The Legal Advocate
cbdMD Inc. (YCBD) Slightly Lower as Stock Hovers Near Key Support at $0.71Revenue Weighted - newsline.com
YCBD Q1 2026 Earnings: EPS Misses Estimates as CBD Market Headwinds PersistEPS Consistency Score - thelegaladvocate.com
cbdMD Inc. (YCBD) Slips 2% as Stock Tests Key Support Near $0.70SuperTrend - The Legal Advocate
cbdMD extends Charlotte lease with reduced space and rent through 2031 - Investing.com Canada
cbdMD Amends Lease, Adjusts Long-Term Facility Commitments - TipRanks
cbdMD, Inc. (YCBD) Files 8-K Announcing Material Definitive Agreement and Financial Obligation – May 20, 2026 - Minichart
Lease change at cbdMD (NYSE: YCBD) cuts annual rent and shrinks footprint - Stock Titan
cbdMD Q1 earnings preview - MSN
Maxim Group Maintains CbdMD(YCBD.US) With Buy Rating, Maintains Target Price $2 - Moomoo
cbdMD, Inc. (AMEX:YCBD) Q3 2026 Earnings Call Transcript - Insider Monkey
cbdMD, Inc. (AMEX:YCBD) Q2 2026 Earnings Call Transcript - Insider Monkey
Cbdmd Inc Earnings Call: Growth Amid Margin Pressure - TipRanks
cbdMD Q2 2026 Loss Deepens: -$0.08/Share vs -$0.05 Expected - AlphaStreet
cbdMD Q2 2026 Deep Dive: EPS Misses by 60.0%, Revenue Up 19% - AlphaStreet
CbdMD, Inc. (YCBD) Q2 2026 Earnings Call Transcript Summary - Moomoo
Earnings call transcript: cbdMD’s Q2 2026 sees revenue boost, margin dip By Investing.com - Investing.com South Africa
Earnings call transcript: cbdMD’s Q2 2026 sees revenue boost, margin dip - Investing.com UK
Transcript : CbdMD, Inc., Q2 2026 Earnings Call, May 14, 2026 - marketscreener.com
Full Transcript: cbdMD Q2 2026 Earnings Call - Benzinga
cbdMD reports 19% revenue growth in fiscal Q2 - Investing.com
cbdMD reports 19% revenue growth in fiscal Q2 By Investing.com - Investing.com Australia
CbdMD reports 19% year-over-year and 12% sequential revenue growth - marketscreener.com
CbdMD Reports 19% Year-Over-Year And 12% Sequential Revenue Growth - TradingView
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - Fidelity
Press Release: CbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - Moomoo
cbdMD (YCBD) grows revenue but warns on going concern and hemp rule risks - Stock Titan
cbdMD, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings Preview: CbdMD to Report Financial Results Post-market on May 14 - Moomoo
Number of shareholders of cbdMD, Inc. – AMEX:YCBD - TradingView
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results - Yahoo Finance
TradingKey - TradingKey
MSN Money - msn.com
Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 22, 2023 - TMX Newsfile
EU's Food Safety Authority Validates cbdMD's Hemp Extract Formulation - TMX Newsfile
cbdMD Expands its Reach to The United Kingdom with Launch on Amazon UK - TMX Newsfile
Juan Archuleta Defends Belt at Bellator 258 - cbdMD
Hawkeye Systems Announces New Board Members With Deep Capital Markets, Governance, Legal, and Merchant Banking Experience - FinancialContent
cbdMD Launches Line of CBD Products with Wegmans Food Markets - TMX Newsfile
$cbdMD (YCBD.US)$ you can run like AKAN, I don’t mind at all 😅🤣. - Moomoo
cbdMD Inc Stock (YCBD) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.24%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):